National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

allogeneic dendritic cell-myeloma idiotype vaccine
A cell-based vaccine composed of allogeneic dendritic cells pulsed ex-vivo with an autologous myeloma idiotype with potential antineoplastic activity. Upon administration, allogeneic dendritic cell-myeloma idiotype vaccine may stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against myeloma cells, resulting in cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:ALIMTA, alitretinoin, Alkeran, allogeneic B7.1/HLA-A1 transfected tumor cell vaccine, allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28
Next:allogeneic GM-CSF-secreting breast cancer vaccine, allogeneic large multivalent immunogen melanoma vaccine LP2307, allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes, allogeneic melanoma vaccine AGI-101H, allogeneic multipotent adult progenitor cells

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov